HSBC upgraded Novo Nordisk (NVO) to Buy from Hold with a $70 price target
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NVO:
- Pfizer Stock (PFE) Price Forecast! Analysts Reaffirm Buy Ratings after Trump Pricing Deal
- Moderately bullish activity in Novo Nordisk with shares down 1.23%
- LifeMD offers Ozempic at $499 per month via Novo Nordisk collaboration
- EA acquired in go-private deal for $55B, Carnival reports Q3 beat: Morning Buzz
- Morning Movers: Tilray rises as Trump touts CBD benefits for seniors